Search Results - "Wurm, Alexander A."
-
1
Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia
Published in Frontiers in oncology (11-09-2019)“…Acute myeloid leukemia is a hematopoietic neoplasm of dismal prognosis that results from the accumulation of immature myeloid blasts in the bone marrow and the…”
Get full text
Journal Article -
2
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia
Published in Frontiers in immunology (22-10-2018)“…Despite the constant development of innovative therapeutic options for hematological malignancies, the gold-standard therapy regimen for curative treatment…”
Get full text
Journal Article -
3
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS‐mutant melanoma cells: Insights into mode of action and resistance mechanisms
Published in International journal of cancer (15-03-2024)“…About 25% of melanoma harbor activating NRAS mutations, which are associated with aggressive disease therefore requiring a rapid antitumor intervention…”
Get full text
Journal Article -
4
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision
Published in Leukemia (01-10-2021)“…Protein-coding and non-coding genes like miRNAs tightly control hematopoietic differentiation programs. Although miRNAs are frequently located within introns…”
Get full text
Journal Article -
5
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
Published in Cell death and differentiation (01-04-2017)“…Development of hematopoietic populations through the process of differentiation is critical for proper hematopoiesis. The transcription factor CCAAT/enhancer…”
Get full text
Journal Article -
6
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
Published in Cell death & disease (26-07-2018)“…Hematopoiesis, the formation of blood cells from hematopoietic stem cells (HSC), is a highly regulated process. Since the discovery of microRNAs (miRNAs),…”
Get full text
Journal Article -
7
Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
Published in Cell death and differentiation (2019)“…Since publication of this article, the authors identified an error in the acknowledgments section. The original sentence in acknowledgments reads as follows:…”
Get full text
Journal Article -
8
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
Published in Cell reports. Medicine (17-10-2023)“…Targeted therapies are effective in treating cancer, but success depends on identifying cancer vulnerabilities. In our study, we utilize small RNA sequencing…”
Get full text
Journal Article -
9
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
Published in Blood cancer journal (New York) (21-03-2018)Get full text
Journal Article -
10
PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia
Published in Cancer research (Chicago, Ill.) (15-08-2015)“…In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. microRNAs…”
Get full text
Journal Article -
11
-
12
EVI2B is a C/EBP[alpha] target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
Published in Cell death and differentiation (01-04-2017)“…Development of hematopoietic populations through the process of differentiation is critical for proper hematopoiesis. The transcription factor CCAAT/enhancer…”
Get full text
Journal Article -
13
Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia
Published in Blood advances (06-11-2024)“…In 2022, the European LeukemiaNet (ELN) risk stratification for patients with AML has been updated. We aimed to validate the prognostic value of the 2022 ELN…”
Get full text
Journal Article -
14
Abstract 4110: Pathway activation driven miRNA depletion highlights cancer signaling vulnerabilities and targeted therapy sensitivity
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Identification of cancer vulnerabilities is pivotal for the success of precision oncology. Comprehensive molecular profiling technologies improved…”
Get full text
Journal Article